Methotrexate, Rituximab, Temozolomide (MRT) Induction Therapy for Elderly Patients with Primary Central Nervous System Lymphoma (PCNSL)

被引：0
|
作者：
Forst, Deborah [1 ]
Chi, Andrew [1 ]
Dietrich, Jorg [1 ]
Gerstner, Elizabeth [1 ]
Jones, SooAe [1 ]
Byrne, Thomas [1 ]
Hochberg, Fred [1 ]
Plotkin, Scott [1 ]
Batchelor, Tracy [1 ]
机构：
[1] Massachusetts Gen Hosp, Stephen E & Catherine Pappas Ctr Neurooncol, Boston, MA 02114 USA
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IN101002
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Primary temozolomide chemotherapy in elderly patients with primary CNS lymphoma (PCNSL)
    Herrlinger, U
    Uhl, M
    Weller, M
    NEURO-ONCOLOGY, 2005, 7 (03) : 314 - 315
  • [22] Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
    Fritsch, K.
    Kasenda, B.
    Hader, C.
    Nikkhah, G.
    Prinz, M.
    Haug, V.
    Haug, S.
    Ihorst, G.
    Finke, J.
    Illerhaus, G.
    ANNALS OF ONCOLOGY, 2011, 22 (09) : 2080 - 2085
  • [23] High-dose methotrexate (HD-MTX) neoadjuvant chemotherapy for primary central nervous system lymphoma (PCNSL) in elderly patients
    Zhu, J.
    NEURO-ONCOLOGY, 2006, 8 (04) : 455 - 455
  • [24] Orelabrutinib, rituximab, temozolomide and high-dose methotrexate (RMOT) in newly diagnosed primary central nervous system lymphoma (PCNSL): A retrospective analysis on efficacy and safety.
    Xia, Yi
    Cai, Qingqing
    Zhang, Peng
    Tian, Xiaopeng
    Fang, Xiaojie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] A Series of Patients with Primary Central Nervous System Lymphoma (PCNSL) and AIDS
    Eisenstein, J. E.
    Mosunjac, M. B.
    LABORATORY INVESTIGATION, 2010, 90 : 333A - 333A
  • [26] Angiogenesis in primary central nervous system lymphoma (PCNSL)
    Hiroaki Takeuchi
    Ken Matsuda
    Ryuhei Kitai
    Kazufumi Sato
    Toshihiko Kubota
    Journal of Neuro-Oncology, 2007, 84 : 141 - 145
  • [27] Comparison of high-dose methotrexate (HDMTX) toxicity in elderly and younger patients (pts) with primary central nervous system lymphoma (PCNSL).
    Jahnke, K
    Korfel, A
    Martus, P
    Weller, M
    Herrlinger, U
    Fischer, L
    Thiel, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 739S - 739S
  • [28] Efficacy and Safety of Intensive Etoposide Aracytine Consolidation Following Rituximab Methotrexate Temozolomide Induction in Newly Diagnosed Primary Central Nervous System Lymphoma
    Birsen, Rudy
    Blanc, Estelle
    Burroni, Barbara
    Broudin, Chloe
    Willems, Lise
    Legoff, Marielle
    Leray, Emmanuelle
    Pilorge, Sylvain
    Salah, Sawsen
    Quentin, Aude
    Deau-Fisher, Benedicte
    Franchi, Patricia
    Vignon, Marguerite
    Mabille, Laurence
    Nguyen, Charles
    Kirova, Youlia
    Varlet, Pascale
    Tauziede-Espariat, Arnault
    Edjlali, Myriam
    Edouard, Dezamis
    Soussain, Carole
    Houillier, Caroline
    Pallud, Johan
    Damotte, Diane
    Bouscary, Didier
    Bonnefoy, Jerome Tamburini
    BLOOD, 2017, 130
  • [29] A Series of Patients with Primary Central Nervous System Lymphoma (PCNSL) and AIDS
    Eisenstein, J. E.
    Mosunjac, M. B.
    MODERN PATHOLOGY, 2010, 23 : 333A - 333A
  • [30] HIGH-DOSE METHOTREXATE, RITUXIMAB, AND TEMOZOLOMIDE (M/R/T) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (PCNSL)
    Gerstner, Elizabeth
    Hochberg, Fred
    Plotkin, Scott
    Eichler, April
    Batchelor, Tracy
    NEURO-ONCOLOGY, 2009, 11 (05) : 627 - 627
12345